Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
inhibitor for protein type-1 phosphatase (PP1) and myosin light-chain phosphatase (MLCP)\\\\; substrate of protein kinase C (PKC) [RGD, Feb 2006]..
Showing 4 out of 7 products:
Whereas CPI-17 staining was diffuse, PHI-1 was concentrated along the cell membrane in distinct foci. The common tissue distribution but different cellular localization of PHI-1 and CPI-17 suggest distinctive physiological roles for these PP1 inhibitors.
PHI-1 participates in regulatory events at the trailing edge of migrating cells and modulates retraction of endothelial and epithelial cells
An inhibitory phosphoprotein that inhibits the myosin- and glycogen-associated holoenzyme versions of protein type-1 phosphatase (PP1) as well as the monomeric catalytic subunit of PP1 in multiple tissues.
results indicate that phosphorylation of I-1 at Ser67 and Thr75 is associated with increased PP1 activity and depressed cardiomyocyte Ca(2 (show CA2 ELISA Kits)+)-cycling, which manifests in geometrical alterations over the long term
inhibitor for protein type-1 phosphatase (PP1) and myosin light-chain phosphatase (MLCP)\; substrate of protein kinase C (PKC)
phospholipase C beta-3 neighboring gene protein
, phospholipase C-beta-3 neighbouring gene protein
, protein phosphatase 1 regulatory subunit 14B
, phosphatase holoenzyme inhibitor 1
, phospholipase c neighboring
, protein phosphatase 1, regulatory (inhibitor) 5 subunit 14B
, ubiquitous PKC-potentiated PP1 inhibitor